HIV AIDS drug resistance: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
'''HIV Drug Resistance''' occurs when [[microevolution]] causes [[virions]] to become tolerant to [[antiretroviral]] treatments. | '''HIV Drug Resistance''' occurs when [[microevolution]] causes [[virions]] to become tolerant to [[antiretroviral]] treatments. | ||
==Current scenario== | ==Current scenario== | ||
Nearly all drugs currently used to treat HIV eventually stop working when patient develops resistance to [[AIDS medical therapy#Anti Retroviral Therapy (ART)|ART]]. HIV develops resistance when it evades the effects of these treatments.<ref name="Freeman">Freeman, S., and J. C. Herron. 2007. Evolutionary Analysis. 4th ed. A case for evolutionary thinking: understanding HIV. Pearson Benjamin Cummings, San Francisco, CA.</ref> A recent study estimated the percentage of the American HIV positive population with some form of drug resistance to be 76.3%.<ref>Richman, D. D., S. C. Morton, T. Wrin, N. Hellmann, S. Berry, M. F. Shapiro, and S. A. Bozzette. 2004. The prevalence of antiretroviral drug resistance in the United States. AIDS. 18: 1393-1401.</ref> | |||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 11:35, 26 May 2012
Overview
HIV Drug Resistance occurs when microevolution causes virions to become tolerant to antiretroviral treatments.
Current scenario
Nearly all drugs currently used to treat HIV eventually stop working when patient develops resistance to ART. HIV develops resistance when it evades the effects of these treatments.[1] A recent study estimated the percentage of the American HIV positive population with some form of drug resistance to be 76.3%.[2]
Reference
- ↑ Freeman, S., and J. C. Herron. 2007. Evolutionary Analysis. 4th ed. A case for evolutionary thinking: understanding HIV. Pearson Benjamin Cummings, San Francisco, CA.
- ↑ Richman, D. D., S. C. Morton, T. Wrin, N. Hellmann, S. Berry, M. F. Shapiro, and S. A. Bozzette. 2004. The prevalence of antiretroviral drug resistance in the United States. AIDS. 18: 1393-1401.